Dr Daniel Durocher
Bernard and Francine Dorval Prize co-recipient in 2010
Dr Durocher is a senior investigator at the Centre for Systems Biology at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto. His discoveries have included the finding of a critical switch for ending a DNA repair response, the biology of chromosome rearrangements and the regulation of chromosome caps or ‘telomeres’ in cells. All these findings have shed important light on the process by which normal cells become cancerous.
Dr Durocher obtained his PhD in 1998 from McGill University and joined the Samuel Lunenfeld Research Institute in 2001 as an investigator with the Centre for Systems Biology. In 2007, he was promoted to associate professor at the Department of Molecular Genetics at the University of Toronto. Dr Durocher is the Thomas Kierans Research Chair in Mechanisms of Cancer Development. He frequently acts as a mentor for scientific trainees and junior faculty.
Dr Durocher has won numerous awards, including a “Canada’s Top 40 Under 40” award in 2010. He has published 47 papers, most often as the senior/corresponding author. His invitations to international meetings indicate he is internationally respected in this highly competitive field. He has also been recognized at home by a Tier-2 Canada Research Chair which was successfully renewed in 2006.
My favourite thing about Camp Goodtime is being able to hang out with other kids who have survived cancer. They know what is going on in your life and can help you get through it.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.